The InterMune Settlement: Deferred Prosecution Agreements in the Context of Off-Label InvestigationsProsecution Agreement • December 13th, 2006
Contract Type FiledDecember 13th, 2006– U.S. stated that “the vast majority of Actimmune sales during the period of August 2002 through January 2003 were attributable to prescriptions for the treatment of idiopathic pulmonary fibrosis (IPF) for which there is no FDA-approved treatment”